Substituted imidazoquinolines
US11267813B2 · kind B2 · utility
1Cited by
3References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 31, 2018 |
| Grant date | Mar 8, 2022 |
| Priority date | — |
| Expiry date | Aug 31, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention relates to imidazoquinoline derivatives and to pharmaceutical compositions containing the imidazoquinoline derivatives. The imidazoquinoline derivatives of the invention are useful as toll-like receptor agonists, in particular agonists of TLR7, and promote induction of certain cytokines.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.